The K–Cl cotransporter KCC3 is mutant in a severe peripheral neuropathy associated with agenesis of the corpus callosum

Article metrics

  • A Corrigendum to this article was published on 01 December 2002

Abstract

Peripheral neuropathy associated with agenesis of the corpus callosum (ACCPN) is a severe sensorimotor neuropathy associated with mental retardation, dysmorphic features and complete or partial agenesis of the corpus callosum. ACCPN is transmitted in an autosomal recessive fashion and is found at a high frequency in the province of Quebec, Canada. ACCPN has been previously mapped to chromosome 15q. The gene SLC12A6 (solute carrier family 12, member 6), which encodes the K+–Cl transporter KCC3 and maps within the ACCPN candidate region, was screened for mutations in individuals with ACCPN. Four distinct protein-truncating mutations were found: two in the French Canadian population and two in non–French Canadian families. The functional consequence of the predominant French Canadian mutation (2436delG, Thr813fsX813) was examined by heterologous expression of wildtype and mutant KCC3 in Xenopus laevis oocytes; the truncated mutant is appropriately glycosylated and expressed at the cellular membrane, where it is non-functional. Mice generated with a targeted deletion of Slc12a6 have a locomotor deficit, peripheral neuropathy and a sensorimotor gating deficit, similar to the human disease. Our findings identify mutations in SLC12A6 as the genetic lesion underlying ACCPN and suggest a critical role for SLC12A6 in the development and maintenance of the nervous system.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Figure 1: Mutations in SLC12A6 found in persons with ACCPN.
Figure 2: Immunoblotting of wildtype and mutant KCC3 proteins.
Figure 3: Immunofluorescence studies of wildtype and mutant KCC3 proteins in X. laevis oocytes (×200 magnification throughout).
Figure 4: Functional expression of wildtype and mutant KCC3.
Figure 5: Disruption of mouse Slc12a6.
Figure 6: Assessment of locomotor and sensorimotor deficits in Slc12a6-mutated mice.
Figure 7: Histological examination of peripheral nerves of Slc12a6-null mice.

Accession codes

Accessions

GenBank/EMBL/DDBJ

Change history

  • 16 October 2002

    This was incorrect in AOP version but corrected in print. Changed the size of the bands in this subsection as stated in the note.

Notes

  1. 1.

    Note: In the AOP version of this article, the sizes of the bands from the mutant KCC3Q protein were stated incorrectly in the Results subsection titled "Immunoblotting and immunofluorescence microscopy." The sizes of the bands were actually 90 kD and 115 kD, rather than 90kD and 120 kD as stated. The full-text online version of the article has been corrected and the article will appear correctly in an upcoming print issue.

References

  1. 1

    Mathieu, J., Bedard, F., Prevost, C. & Langevin, P. Motor and sensory neuropathies with or without agenesis of the corpus callosum: a radiological study of 64 cases. Can. J. Neurol. Sci. 17, 103–108 (1990).

  2. 2

    Larbrisseau, A., Vanasse, M., Brochu, P. & Jasmin, G. The Andermann syndrome: agenesis of the corpus callosum associated with mental retardation and progressive sensorimotor neuronopathy. Can. J. Neurol. Sci. 11, 257–261 (1984).

  3. 3

    Andermann, E. Sensorimotor neuropathy with agenesis of the corpus callosum. in Handbook of Clinical Neurology Vol. 42 (ed. Vinken, P.J.) 100–103 (North Holland, Amsterdam, 1981).

  4. 4

    Andermann, F., Andermann, E. & Joubert, M. Familial agenesis of the corpus callosum with anterior horn cell disease: a syndrome of mental retardation, areflexia, and paraparesis. Trans. Am. Neurol. Assoc. 1972, 242–244 (1972).

  5. 5

    Filteau, M.J. et al. Corpus callosum agenesis and psychosis in Andermann syndrome. Arch. Neurol. 48, 1275–1280 (1991).

  6. 6

    De Braekeleer, M., Dallaire, A. & Mathieu, J. Genetic epidemiology of sensorimotor polyneuropathy with or without agenesis of the corpus callosum in northeastern Quebec. Hum. Genet. 91, 223–227 (1993).

  7. 7

    Hauser, E., Bittner, R., Liegl, C., Bernert, G. & Zeitlhofer, J. Occurrence of Andermann syndrome out of French Canada—agenesis of the corpus callosum with neuronopathy. Neuropediatrics 24, 107–110 (1993).

  8. 8

    Battistella, P.A. Occurrence of Andermann syndrome out of French Canada—agenesis of the corpus callosum with neuronopathy [Comment]. Neuropediatrics 24, 239 (1993).

  9. 9

    Gurtubay, I.G. et al. Andermann syndrome: presentation of a case. Rev. Neurol. 25, 1087–1090 (1997).

  10. 10

    Deleu, D., Bamanikar, S.A., Muirhead, D. & Louon, A. Familial progressive sensorimotor neuropathy with agenesis of the corpus callosum (Andermann syndrome): a clinical, neuroradiological and histopathological study. Eur. Neurol. 37, 104–109 (1997).

  11. 11

    Lesca, G. et al. Andermann syndrome in an Algerian family: suggestion of phenotype and genetic homogeneity. Rev. Neurol. (Paris) 157, 1279–1281 (2001).

  12. 12

    Casaubon, L.K. et al. The gene responsible for a severe form of peripheral neuropathy and agenesis of the corpus callosum maps to chromosome 15q. Am. J. Hum. Genet. 58, 28–34 (1996).

  13. 13

    Howard, H. et al. Fine mapping the candidate region for peripheral neuropathy with or without agenesis of the corpus callosum in the French Canadian population. Eur. J. Hum. Genet. 10, 406–412 (2002).

  14. 14

    Mount, D.B. et al. Cloning and characterization of KCC3 and KCC4, new members of the cation-chloride cotransporter gene family. J. Biol. Chem. 274, 16355–16362 (1999).

  15. 15

    Hiki, K. et al. Cloning, characterization, and chromosomal location of a novel human K+-Cl cotransporter. J. Biol. Chem. 274, 10661–10667 (1999).

  16. 16

    Delpire, E. & Mount, D.B. Human and murine phenotypes associated with defects in cation-chloride cotransport. Annu. Rev. Physiol. 64, 803–843 (2002).

  17. 17

    Pearson, M., Lu, J., Mount, D.B. & Delpire, E. Localization of the K-Cl cotransporter, KCC3, in the central and peripheral nervous systems: expression in choroid plexus, large neurons, and white matter tracts. Neuroscience 103, 483–493 (2001).

  18. 18

    Casula, S. et al. A dominant negative mutant of the KCC1 K-Cl cotransporter: both N- and C-terminal cytoplasmic domains are required for K-Cl cotransport activity. J. Biol. Chem. 276, 41870–41878 (2001).

  19. 19

    Moore-Hoon, M.L. & Turner, R.J. The structural unit of the secretory Na+-K+-2Cl- cotransporter (NKCC1) is a homodimer. Biochemistry 39, 3718–3724 (2000).

  20. 20

    Mercado, A. et al. Functional and molecular characterization of the K-Cl cotransporter of Xenopus laevis oocytes. Am J. Physiol. Cell. Physiol. 281, C670–C680 (2001).

  21. 21

    Carpenter, S. The pathology of the Andermann Syndrome. in Callosal Agenesis: A Natural Split Brain? (eds Lassonde, M. & Jeeves, M.) 27–30 (Plenum, New York, 1994).

  22. 22

    Zhuchenko, O. et al. Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the α1A–voltage-dependent calcium channel. Nat. Genet. 15, 62–69 (1997).

  23. 23

    Kelsell, D.P., Dunlop, J. & Hodgins, M.B. Human diseases: clues to cracking the connexin code? Trends Cell. Biol. 11, 2–6 (2001).

  24. 24

    Bomont, P. et al. The gene encoding gigaxonin, a new member of the cytoskeletal BTB/kelch repeat family, is mutated in giant axonal neuropathy. Nat. Genet. 26, 370–374 (2000).

  25. 25

    Scriver, C.R. Human genetics: lessons from Quebec populations. Annu. Rev. Genomics Hum. Genet. 2, 69–101 (2001).

  26. 26

    Martin, M.G., Turk, E., Lostao, M.P., Kerner, C. & Wright, E.M. Defects in Na+/glucose cotransporter (SGLT1) trafficking and function cause glucose–galactose malabsorption. Nat. Genet. 12, 216–220 (1996).

  27. 27

    Kunchaparty, S. et al. Defective processing and expression of thiazide-sensitive Na-Cl cotransporter as a cause of Gitelman's syndrome. Am. J. Physiol. 277, F643–F649 (1999).

  28. 28

    Strange, K., Singer, T.D., Morrison, R. & Delpire, E. Dependence of KCC2 K-Cl cotransporter activity on a conserved carboxy terminus tyrosine residue. Am. J. Physiol. Cell. Physiol. 279, C860–C867 (2000).

  29. 29

    Magara, F. et al. Genetic background changes the pattern of forebrain commissure defects in transgenic mice underexpressing the β-amyloid-precursor protein. Proc. Natl Acad. Sci. USA 96, 4656–4661 (1999).

  30. 30

    Braff, D.L., Geyer, M.A. & Swerdlow, N.R. Human studies of prepulse inhibition of startle: normal subjects, patients groups, and pharmacological studies. Psychopharmacology 2001, 234–258 (2001).

  31. 31

    Freedman, R. et al. Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus. Proc. Natl Acad. Sci. USA 94, 587–592 (1997).

  32. 32

    Lauf, P.K. & Adragna, N.C. K-Cl cotransport: properties and molecular mechanism. Cell. Physiol. Biochem. 10, 341–354 (2000).

  33. 33

    Shen, M.R. et al. The KCl cotransporter isoform KCC3 can play an important role in cell growth regulation. Proc. Natl Acad. Sci. USA 98, 14714–14719 (2001).

  34. 34

    Cheng, C.M. et al. Biochemical and morphometric analyses show that myelination in the insulin-like growth factor 1 null brain is proportionate to its neuronal composition. J. Neurosci. 18, 5673–5681 (1998).

  35. 35

    Sambrook, J., Fritsch, E. & Maniatis, T. (eds) Molecular Cloning: A Laboratory Manual (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 1989).

  36. 36

    Orita, M., Suzuki, Y., Sekiya, T. & Hayashi, K. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics 5, 874–879 (1989).

  37. 37

    Mountford, P. et al. Dicistronic targeting constructs: reporters and modifiers of mammalian gene expression. Proc. Natl Acad. Sci. USA 91, 4303–4307 (1994).

  38. 38

    Liu, Y. et al. Mouse model of GM2 activator deficiency manifests cerebellar pathology and motor impairment. Proc. Natl Acad. Sci. USA 94, 8138–8143 (1997).

  39. 39

    Norflus, F. et al. Bone marrow transplantation prolongs life span and ameliorates neurologic manifestations in Sandhoff disease mice. J. Clin. Invest. 101, 1881–1888 (1998).

  40. 40

    Lijam, N. et al. Social interaction and sensorimotor gating abnormalities in mice lacking Dvl1. Cell 90, 895–905 (1997).

Download references

Acknowledgements

We would like to thank all the families who participated in this study; the Vanderbilt Ingram Cancer Center Transgenic/ES Cell Shared Resource Core for expertise and help; R. Desai for technical assistance; the Tennessee Mouse Genome Consortium Neurohistology Core; and C. Laberge for providing DNA from control subjects from the Saguenay region. This work was supported by La Fondation des jumelles Coudés, the Canadian Institute for Health Research and the US National Institutes of Health. D.B.M. was also supported by a VA Advanced Research Career Development Award.

Author information

Correspondence to Eric Delpire or Guy A. Rouleau.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Web Movie A

Open-field analysis of KCC3 wildtype (+/+) and knockout (-/-) mice. Whereas the wildtype mouse moves freely in the cage without disrupting the corncob substrate, the knockout mouse slips and leaves wide tracks in the bedding.

Rights and permissions

Reprints and Permissions

About this article

Further reading